Several studies have shown that the serum expression level of pro-surfactant protein B (pro-SFTPB) is increased in patients with lung cancer, with a poor prognosis and shorter survival, thus indicating a diagnostic and prognostic role of serum pro-SFTPB in detecting human cancer [224,225,226,227]. Here, SFTPB is linked to lung carcinoma.